ARCT-154

self-amplifying RNA vaccine targeting SARS-CoV-2 · Vinbiocare Biotechnology Joint Stock Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARCT-154, covering 2025-11-06 to 2025-11-06. Get the full timeline:

Most recent: Clinical Trial Update: The ARCT-154 Self-Amplifying RNA Vaccine Efficacy Study (ARCT-154-01) [Phase 2, Phase 3]